Nursing, morality, and emotions: Phase I and phase II clinical trials and patients with cancer

被引:13
|
作者
Krishnasamy, M [1 ]
机构
[1] Royal Marsden Hosp, NHS Trust, Ctr Canc & Palliat Care Studies, Macmillan Practice Dev Unit,Inst Canc Res, London SW3 6JJ, England
关键词
cancer clinical trials; care; emotions; moral distress;
D O I
10.1097/00002820-199908000-00001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article reflects three nurses' views of the moral dimensions of their work in caring for patients receiving phases I and II of cancer clinical trials in a dedicated cancer clinical trials unit (CCTU). The nurses took part in a semistructured, tape-recorded, group interview in which they talked about any aspect of their work that they felt demonstrated its ethical or moral dimensions. The nurses were not employed as research nurses, but had chosen to specialize in cancer and palliative care in a CCTU environment. Three key themes emerged from the interview: being valued and moral distress; caring in a climate of scientific research; and care, cure, and consequences for moral reasoning. Working in an environment suffused with moral conflicts can be painful and damaging for the professionals involved. It would appear that if nurses are to function effectively they need to be proactive in promoting an exploration of the role that emotions play in moral decision making and in examining the contribution of emotions to what they care about and why. A commitment to a shared understanding and valuing of divergent ethical reasoning in and across professional cultures of care and research paradigms also appears to be necessary. The terms "ethics" and "morals" are used interchangeably throughout this article.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 50 条
  • [1] Phase I and II Clinical Trials for Gastric Cancer
    Khushalani, Nikhil I.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 21 (01) : 113 - +
  • [2] Phase I Cancer Clinical Trials
    J A Ledermann
    [J]. British Journal of Cancer, 2007, 96 (8) : 1311 - 1311
  • [3] Phase I and II clinical trials of trastuzumab
    Baselga, J
    [J]. ANNALS OF ONCOLOGY, 2001, 12 : 49 - 55
  • [4] Phase I and II clinical trials for the mucopolysaccharidoses
    Poswar, Fabiano
    Baldo, Guilherme
    Giugliani, Roberto
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (12) : 1331 - 1340
  • [5] Evaluation of statistical designs of phase I/II clinical trials for cancer patients published in 2005
    Houede, N.
    Kramar, A.
    Paoletti, X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
    Nurgat, ZA
    Craig, W
    Campbell, NC
    Bissett, JD
    Cassidy, J
    Nicolson, MC
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1001 - 1005
  • [7] Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
    Z A Nurgat
    W Craig
    N C Campbell
    J D Bissett
    J Cassidy
    M C Nicolson
    [J]. British Journal of Cancer, 2005, 92 : 1001 - 1005
  • [8] Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials
    Molfino, Alessio
    Amabile, Maria Ida
    Giorgi, Antonella
    Monti, Massimo
    D'Andrea, Vito
    Muscaritoli, Maurizio
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (08) : 733 - 740
  • [9] Phase II Cancer Prevention Clinical Trials
    Szabo, Eva
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (04) : 359 - 366
  • [10] Investigational drugs in phase I and phase II clinical trials for thalassemia
    Motta, Irene
    Scaramellini, Natalia
    Cappellini, Maria Domenica
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (07) : 793 - 802